{"id":13029,"date":"2019-04-11T09:26:44","date_gmt":"2019-04-11T13:26:44","guid":{"rendered":"https:\/\/medicarereport.org\/?p=13029"},"modified":"2019-04-11T09:26:44","modified_gmt":"2019-04-11T13:26:44","slug":"pharma-lobbyists-flooded-maryland-to-block-a-drug-pricing-bill-opponents-pushed-back-and-won","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=13029","title":{"rendered":"Pharma lobbyists flooded Maryland to block a drug-pricing bill. Opponents pushed back \u2014 and won"},"content":{"rendered":"<p>(By Lev Facher for ST<em>A<\/em>T)<\/p>\n<p>ANNAPOLIS, Md. \u2014 The drug industry has long been seen as invincible in this small state capital, where last year it retained more than 100 lobbyists: two for every state senator, plus a dozen to spare.\u00a0 Continue reading <a href=\"https:\/\/www.statnews.com\/2019\/04\/11\/pharma-lobbyists-flooded-maryland-to-block-a-drug-pricing-bill-opponents-pushed-back-and-won\/?utm_campaign=KHN%3A%20First%20Edition&amp;utm_source=hs_email&amp;utm_medium=email&amp;utm_content=71658543&amp;_hsenc=p2ANqtz-8FIWsx0shRwgoy36Sw6n_Zer2OZN-GkoVKjCVFzIfHe1V5x2vbRjjmmqnqZ1SjDmUt2toamoEOmszZ1YwZ43f_AYwq0g&amp;_hsmi=71658543\">article here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4372\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png\" alt=\"\" width=\"300\" height=\"32\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre>Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By Lev Facher for STAT) ANNAPOLIS, Md. \u2014 The drug industry has long been seen as invincible in this small<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,20,15],"tags":[],"class_list":["post-13029","post","type-post","status-publish","format-standard","hentry","category-health-care-general","category-health-care-redesign","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13029","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13029"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13029\/revisions"}],"predecessor-version":[{"id":13030,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13029\/revisions\/13030"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13029"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13029"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13029"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}